Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14007)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Streba LAM, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World J Gastroenterol 2015; 21(14): 4103-4110 [PMID: 25892859 DOI: 10.3748/wjg.v21.i14.4103] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i14/4103.htm |
| Number | Citing Articles |
| 1 |
Li Yang. Nonalcoholic fatty liver disease and colorectal cancer: a two-sample bidirectional Mendelian randomization analysis. European Journal of Gastroenterology & Hepatology 2024; 36(12): 1447 doi: 10.1097/MEG.0000000000002859
|
| 2 |
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
|
| 3 |
Judith Lauvai, Monika Schumacher, Fernanda Dias Bartolomeu Abadio Finco, Lutz Graeve. Bacaba phenolic extract attenuates adipogenesis by down-regulating PPARγ and C/EBPα in 3T3-L1 cells. NFS Journal 2017; 9: 8 doi: 10.1016/j.nfs.2017.09.001
|
| 4 |
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
|
| 5 |
P. Shabani, S. Emamgholipour, M. Doosti. . Advances in Clinical Chemistry 2017; 79: 1 doi: 10.1016/bs.acc.2016.10.002
|
| 6 |
D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver disease. Nutrition Research Reviews 2015; 28(2): 133 doi: 10.1017/S0954422415000128
|
| 7 |
Yasin Şenol, Ozan Kaplan, Cem Varan, Nurbanu Demirtürk, Selin Öncül, Bilge Başak Fidan, Ayşe Ercan, Erem Bilensoy, Mustafa Çelebier. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines. Journal of Drug Delivery Science and Technology 2023; 79: 104017 doi: 10.1016/j.jddst.2022.104017
|
| 8 |
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
|
| 9 |
I. G. Nikitin, A. S. Tikhomirova, T. A. Zhinzhilo, E. V. Vinnitskaya, Y. G. Sandler, V. A. Kislyakov, I. G. Fedorov. Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism. The Russian Archives of Internal Medicine 2020; 10(2): 148 doi: 10.20514/2226-6704-2020-10-2-148-154
|
| 10 |
Fatemeh Rahimi, Yahya Pasdar, Mojtaba Kaviani, Soheil Abbasi, Hillary Fry, Azita Hekmatdoost, Omid Nikpayam, Golbon Sohrab, Mansoaur Rezaei, Seyed Mostafa Nachvak, Reza Mohammadi, Gayatri K. Athalye-Jape. Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial. International Journal of Clinical Practice 2022; 2022: 1 doi: 10.1155/2022/2967977
|
| 11 |
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hiroko Iijima. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. International Journal of Molecular Sciences 2021; 22(4): 1917 doi: 10.3390/ijms22041917
|
| 12 |
Chi Ma, Qianfei Zhang, Tim F. Greten. MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target. Cellular Immunology 2021; 361: 104295 doi: 10.1016/j.cellimm.2021.104295
|
| 13 |
Xushan Yang, Linye Sun, Dongliang Feng, Yudi Deng, Wenzhen Liao. A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation. The Journal of Nutritional Biochemistry 2023; 118: 109353 doi: 10.1016/j.jnutbio.2023.109353
|
| 14 |
Yangni Lu, Xianli Xu, Jianlin Wu, Lei Ji, Huiya Huang, Maowei Chen. Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 2017 to 2020. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03394-6
|
| 15 |
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934
|
| 16 |
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul. Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease. Clinical and Molecular Hepatology 2020; 26(4): 705 doi: 10.3350/cmh.2020.0166
|
| 17 |
Xin Zhang, Yuyin Xu, Qianming Bai, Xiaobo Li, Jing Han, Yingyong Hou, Yuan Ji, Zhigang Zhang. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(1): G87 doi: 10.1152/ajpgi.00380.2019
|
| 18 |
Gang Wang, Ning Zhuo, Zhichun Liu. Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers. Journal of Clinical Oncology 2023; 41(32): 5070 doi: 10.1200/JCO.23.01039
|
| 19 |
Natalia Pydyn, Katarzyna Miękus, Jolanta Jura, Jerzy Kotlinowski. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. Pharmacological Reports 2020; 72(1): 1 doi: 10.1007/s43440-019-00020-1
|
| 20 |
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
|
| 21 |
Yanni Zhang, Jing Sui, Ying Xu, Ling Pan, Hui Xia, Guiju Sun. Effect of whole grain and fiber consumption on chronic liver diseases: a systematic review and meta-analysis. Food & Function 2024; 15(19): 9707 doi: 10.1039/D4FO03077J
|
| 22 |
Natalia Pydyn, Dariusz Żurawek, Joanna Kozieł, Edyta Kus, Kamila Wojnar‐Lason, Agnieszka Jasztal, Mingui Fu, Jolanta Jura, Jerzy Kotlinowski. Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts. The FEBS Journal 2021; 288(22): 6563 doi: 10.1111/febs.16040
|
| 23 |
Natalia Belemets, Nazarii Kobyliak, Oleksandr Virchenko, Tetyana Falalyeyeva, Tsyryuk Olena, Petro Bodnar, Oleksiy Savchuk, Tetyana Galenova, Martin Caprnda, Luis Rodrigo, Lubomir Skladany, Delian Delev, Radka Opatrilova, Peter Kruzliak, Tetyana Beregova, Lyudmyla Ostapchenko. Effects of polyphenol compounds melanin on NAFLD/NASH prevention. Biomedicine & Pharmacotherapy 2017; 88: 267 doi: 10.1016/j.biopha.2017.01.028
|
| 24 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 25 |
Chun-Xiao Liu, Rui-Xing Yin, Zong-Hu Shi, Guo-Xiong Deng, Peng-Fei Zheng, Bi-Liu Wei, Yao-Zong Guan. EHBP1 SNPs, Their Haplotypes, and Gene–Environment Interactive Effects on Serum Lipid Levels. ACS Omega 2020; 5(13): 7158 doi: 10.1021/acsomega.9b03522
|
| 26 |
Pan Deng, Jazmyne Barney, Michael C. Petriello, Andrew J. Morris, Banrida Wahlang, Bernhard Hennig. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction. Chemosphere 2019; 217: 140 doi: 10.1016/j.chemosphere.2018.10.196
|
| 27 |
Emir Muzurović, Dimitri P. Mikhailidis, Christos Mantzoros. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 2021; 119: 154770 doi: 10.1016/j.metabol.2021.154770
|
| 28 |
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty
Liver Disease. Current Drug Targets 2023; 24(4): 300 doi: 10.2174/1389450124666230113150116
|
| 29 |
H. Nina Kim, Craig W. Newcomb, Dena M. Carbonari, Jason A. Roy, Jessie Torgersen, Keri N. Althoff, Mari M. Kitahata, K. Rajender Reddy, Joseph K. Lim, Michael J. Silverberg, Angel M. Mayor, Michael A. Horberg, Edward R. Cachay, Gregory D. Kirk, Jing Sun, Mark Hull, M. John Gill, Timothy R. Sterling, Jay R. Kostman, Marion G. Peters, Richard D. Moore, Marina B. Klein, Vincent Lo Re. Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America. Hepatology 2021; 74(3): 1190 doi: 10.1002/hep.31839
|
| 30 |
Hiroki Koga, Keita Kai, Shinichi Aishima, Atsushi Kawaguchi, Koutaro Yamaji, Takao Ide, Junji Ueda, Hirokazu Noshiro. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma. World Journal of Hepatology 2017; 9(35): 1286-1295 doi: 10.4254/wjh.v9.i35.1286
|
| 31 |
Da-Hye Lee, So-Hyun Park, Jiyun Ahn, Seung Pyo Hong, Eunyoung Lee, Young-Jin Jang, Tae-Youl Ha, Yang Hoon Huh, Seung-Yeon Ha, Tae-Il Jeon, Chang Hwa Jung. Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosis. Autophagy 2021; 17(9): 2415 doi: 10.1080/15548627.2020.1827779
|
| 32 |
Jeane Rebecca Roy, Coimbatore Sadagopan Janaki, Selvaraj Jayaraman, Vishnu Priya Veeraraghavan, Vijayalakshmi Periyasamy, Thotakura Balaji, Madhavan Vijayamalathi, Ponnusamy Bhuvaneswari, Panneerselvam Swetha. Hypoglycemic Potential of Carica papaya in Liver Is Mediated through IRS-2/PI3K/SREBP-1c/GLUT2 Signaling in High-Fat-Diet-Induced Type-2 Diabetic Male Rats. Toxics 2023; 11(3): 240 doi: 10.3390/toxics11030240
|
| 33 |
Eckhard Klieser, Christian Mayr, Tobias Kiesslich, Till Wissniowski, Pietro Di Fazio, Daniel Neureiter, Matthias Ocker. The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications. International Journal of Molecular Sciences 2019; 20(21): 5266 doi: 10.3390/ijms20215266
|
| 34 |
Ayse Ercan, Mustafa Çelebier, Selin Oncul, Gamze Varan, Engin Kocak, Juan M. Benito, Erem Bilensoy. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level. International Journal of Pharmaceutics 2021; 598: 120379 doi: 10.1016/j.ijpharm.2021.120379
|
| 35 |
Monika Gjorgjieva, Maaike H. Oosterveer, Gilles Mithieux, Fabienne Rajas. Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment. Journal of Inborn Errors of Metabolism and Screening 2016; 4: 232640981667942 doi: 10.1177/2326409816679429
|
| 36 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|
| 37 |
Lui Ng, Ryan Wai-Yan Sin, David Him Cheung, Wai-Keung Leung, Abraham Tak-Ka Man, Oswens Siu-Hung Lo, Wai-Lun Law, Dominic Chi-Chung Foo. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients. International Journal of Molecular Sciences 2023; 24(10): 9084 doi: 10.3390/ijms24109084
|
| 38 |
Brennan K. Smith, Katarina Marcinko, Eric M. Desjardins, James S. Lally, Rebecca J. Ford, Gregory R. Steinberg. Treatment of nonalcoholic fatty liver disease: role of AMPK. American Journal of Physiology-Endocrinology and Metabolism 2016; 311(4): E730 doi: 10.1152/ajpendo.00225.2016
|
| 39 |
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. Lifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
|
| 40 |
Kavya Koneru, Varsha Bhatt, Arjun Kakrani, Manaswini Edara, Vuluvala T. Reddy, Pranav Gopal Jawade. A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals. Journal of Family Medicine and Primary Care 2022; 11(8): 4368 doi: 10.4103/jfmpc.jfmpc_58_22
|
| 41 |
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Abdullah Farasani, Saeed M Kabrah, Gaber El-Saber Batiha, Carlos Adam Conte-Junior. Cancer of the Liver and its Relationship with Diabetes mellitus. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338221119743
|
| 42 |
Jau-Shin Hon, Zhi-Yuan Shi, Chen-Yang Cheng, Zong-You Li. Applying Data Mining to Investigate Cancer Risk in Patients with Pyogenic Liver Abscess. Healthcare 2020; 8(2): 141 doi: 10.3390/healthcare8020141
|
| 43 |
Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Wataru Okamoto, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Daiki Miki, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hiroshi Aikata. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01884-5
|
| 44 |
Xinmu Zhang, Ruitang Deng. Nonalcoholic Fatty Liver Disease - An Update. 2019; doi: 10.5772/intechopen.81474
|
| 45 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
|
| 46 |
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
|
| 47 |
Laure Monteillet, Monika Gjorgjieva, Marine Silva, Vincent Verzieux, Linda Imikirene, Adeline Duchampt, Hervé Guillou, Gilles Mithieux, Fabienne Rajas. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Molecular Metabolism 2018; 16: 100 doi: 10.1016/j.molmet.2018.07.006
|
| 48 |
Jin‐Mao Li, Jun Zhou, Zhen Xu, Hai‐Jin Huang, Min‐Jiang Chen, Jian‐Song Ji. MicroRNA‐27a‐3p inhibits cell viability and migration through down‐regulating DUSP16 in hepatocellular carcinoma. Journal of Cellular Biochemistry 2018; 119(7): 5143 doi: 10.1002/jcb.26526
|
| 49 |
Zhen He, Jian Jun Yang, Rong Zhang, Hua Ting Li, Liang Wu, Feng Jiang, Wei Ping Jia, Cheng Hu. Circulating miR‐29b positively correlates with non‐alcoholic fatty liver disease in a Chinese population. Journal of Digestive Diseases 2019; 20(4): 189 doi: 10.1111/1751-2980.12716
|
| 50 |
Neil E. Caporaso, Rena R. Jones, Rachael Z. Stolzenberg-Solomon, Danielle N. Medgyesi, Lisa L. Kahle, Barry I. Graubard. Insulin Resistance in Healthy U.S. Adults: Findings from the National Health and Nutrition Examination Survey (NHANES). Cancer Epidemiology, Biomarkers & Prevention 2020; 29(1): 157 doi: 10.1158/1055-9965.EPI-19-0206
|
| 51 |
Carmen Yagüe-Caballero, Diego Casas-Deza, Andrea Pascual-Oliver, Silvia Espina-Cadena, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde. MASLD-Related Hepatocarcinoma: Special Features and Challenges. Journal of Clinical Medicine 2024; 13(16): 4657 doi: 10.3390/jcm13164657
|
| 52 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
| 53 |
Hiroyo Ota, Yukio Fujita, Motoo Yamauchi, Shigeo Muro, Hiroshi Kimura, Shin Takasawa. Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome. International Journal of Molecular Sciences 2019; 20(19): 4756 doi: 10.3390/ijms20194756
|
| 54 |
Juan-Juan Gu, Min Yao, Jie Yang, Yin Cai, Wen-Jie Zheng, Li Wang, Deng-Bing Yao, Deng-Fu Yao. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World Journal of Gastroenterology 2017; 23(2): 256-264 doi: 10.3748/wjg.v23.i2.256
|
| 55 |
Xushan Yang, Yudi Deng, Yali Tu, Dongliang Feng, Wenzhen Liao. Nobiletin mitigates NAFLD via lipophagy and inflammation. Food & Function 2022; 13(19): 10186 doi: 10.1039/D2FO01682F
|
| 56 |
Charlotte S Benson, Jeremy F Cobbold, Charlotte J Frise. Non-alcoholic fatty liver disease in pregnancy. Obstetric Medicine 2023; 16(2): 116 doi: 10.1177/1753495X211034709
|
| 57 |
Difei Lu, Zhenfang Yuan, Lihua Yang, Yong Jiang, Min Li, Yuanzheng Wang, Lulu Jing, Rongli Wang, Junqing Zhang, Xiaohui Guo, Carlo Sasso. Body Composition and Metabolic Improvement in Patients Followed Up by a Multidisciplinary Team for Obesity in China. Journal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/8862217
|
| 58 |
Mehdi Zobeiri, Fatemeh Parvizi, Mohammad Reza Kalhori, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Mohammad Abdollahi, Mozaniel Oliveira. Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6641031
|
| 59 |
Sumati Rohilla, Savneet Kaur, Rekha Puria. . Advances in Clinical Chemistry 2022; 110: 1 doi: 10.1016/bs.acc.2022.06.001
|
| 60 |
Patricia Rosales-Cruz, Mayra Domínguez-Pérez, Elizabeth Reyes-Zárate, Oscar Bello-Monroy, Cristina Enríquez-Cortina, Roxana Miranda-Labra, Leticia Bucio, Luis Enrique Gómez-Quiroz, Emilio Rojas-Del Castillo, María Concepción Gutiérrez-Ruíz, Verónica Souza-Arroyo. Cadmium exposure exacerbates hyperlipidemia in cholesterol-overloaded hepatocytes via autophagy dysregulation. Toxicology 2018; : 41 doi: 10.1016/j.tox.2018.02.007
|
| 61 |
Judith Lauvai, Anna‐Karina Becker, Katja Lehnert, Monika Schumacher, Bettina Hieronimus, Walter Vetter, Lutz Graeve. The Furan Fatty Acid 9M5 Acts as a Partial Ligand to Peroxisome Proliferator‐Activated Receptor gamma and Enhances Adipogenesis in 3T3‐L1 Preadipocytes. Lipids 2019; 54(5): 277 doi: 10.1002/lipd.12152
|
| 62 |
Jacqueline Córdova-Gallardo, Andrew P. Keaveny, Xingshun Qi, Nahum Méndez-Sánchez. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e84 doi: 10.1097/MEG.0000000000002335
|
| 63 |
Yujie Ma, Jinmei Li, Zhengcai Ju, Wendong Huang, Zhengtao Wang, Li Yang, Lili Ding. Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathway. Journal of Ethnopharmacology 2021; 279: 114320 doi: 10.1016/j.jep.2021.114320
|
| 64 |
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Alimentary Pharmacology & Therapeutics 2018; 48(7): 696 doi: 10.1111/apt.14937
|
| 65 |
Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32722-6
|
| 66 |
Isabela Macedo Lopes Vasques-Monteiro, Flávia Maria Silva-Veiga, Carolline Santos Miranda, Édira Castello Branco de Andrade Gonçalves, Julio Beltrame Daleprane, Vanessa Souza-Mello. A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice. Nutrition Research 2021; 91: 26 doi: 10.1016/j.nutres.2021.04.008
|
| 67 |
Pablo Muriel, Pedro López-Sánchez, Erika Ramos-Tovar. Fructose and the Liver. International Journal of Molecular Sciences 2021; 22(13): 6969 doi: 10.3390/ijms22136969
|
| 68 |
Nissar U. Ashraf, Mohammad Altaf. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease. Mutation Research/Reviews in Mutation Research 2018; 778: 1 doi: 10.1016/j.mrrev.2018.07.002
|
| 69 |
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
|
| 70 |
José A González-Regueiro, Astrid Ruiz-Margáin, Mariana Cruz-Contreras, Ana M Montaña-Duclaud, Andrea Cavazos-Gómez, Roberta Demichelis-Gómez, Ricardo U Macías-Rodríguez. Clinical characteristics and treatment outcomes in patients with liver cirrhosis and lymphoma. World Journal of Hepatology 2020; 12(2): 34-45 doi: 10.4254/wjh.v12.i2.34
|
| 71 |
Duminda Suraweera, Peter Konyn, Thomas Vu, Sammy Saab. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 229 doi: 10.1007/978-3-319-94355-8_15
|
| 72 |
Lena Schulte, Bernhard Scheiner, Torsten Voigtländer, Sandra Koch, Nora Schweitzer, Silke Marhenke, Philipp Ivanyi, Michael P. Manns, Thomas Rodt, Jan B. Hinrichs, Arndt Weinmann, Matthias Pinter, Arndt Vogel, Martha M. Kirstein. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver International 2019; 39(4): 714 doi: 10.1111/liv.14048
|
| 73 |
Marcos C. Carreira, Andrea G. Izquierdo, Maria Amil, Felipe F. Casanueva, Ana B. Crujeiras, Giulio Ceolotto. Oxidative Stress Induced by Excess of Adiposity Is Related to a Downregulation of Hepatic SIRT6 Expression in Obese Individuals. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/6256052
|
| 74 |
Bárbara L. Riestra-Candelaria, Loida A. González-Rodríguez, Wilma Rodriguez-Mojica, Luis E. Vázquez-Quiñones, Juan Carlos Jorge. Sonographic Features of the Liver Among Females With Type 2 Diabetes. Journal of Diagnostic Medical Sonography 2019; 35(3): 189 doi: 10.1177/8756479319834927
|
| 75 |
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
|
| 76 |
Tarana Arman, Katherine D. Lynch, Michelle L. Montonye, Michael Goedken, John D. Clarke. Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats. Toxins 2019; 11(7): 398 doi: 10.3390/toxins11070398
|
| 77 |
Wan Mu, Xue-fang Cheng, Ying Liu, Qian-zhou Lv, Gao-lin Liu, Ji-gang Zhang, Xiao-yu Li. Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues. Frontiers in Pharmacology 2019; 9 doi: 10.3389/fphar.2018.01566
|
| 78 |
Omar Ramos-Lopez, Jose I. Riezu-Boj, Fermin I. Milagro, J. Alfredo Martinez. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes. Nutrition and Cancer 2019; 71(5): 840 doi: 10.1080/01635581.2018.1531136
|
| 79 |
Filomena Morisco, Maria Guarino, Maria R. Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani. Metabolic disorders across hepatocellular carcinoma in Italy. Liver International 2018; 38(11): 2028 doi: 10.1111/liv.13877
|
| 80 |
Jing Sui, Wanshui Yang, Yanan Ma, Tricia Y. Li, Tracey G. Simon, Jeffrey A. Meyerhardt, Geyu Liang, Edward L. Giovannucci, Andrew T. Chan, Xuehong Zhang. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prevention Research 2019; 12(6): 367 doi: 10.1158/1940-6207.CAPR-18-0511
|
| 81 |
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
|
| 82 |
Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li. Clinical impact and mechanisms in hepatitis B virus infection concurrent with non-alcoholic fatty liver disease. Chinese Medical Journal 2022; doi: 10.1097/CM9.0000000000002310
|
| 83 |
Ivana Mikolasevic, Sandra Milic, Lidija Orlic, Davor Stimac, Neven Franjic, Giovanni Targher. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. Journal of Diabetes and its Complications 2016; 30(7): 1347 doi: 10.1016/j.jdiacomp.2016.05.014
|
| 84 |
Mingda Wang, Jun Han, Hao Xing, Han Zhang, Zhenli Li, Lei Liang, Chao Li, Shuyang Dai, Mengchao Wu, Feng Shen, Tian Yang. Dysregulated Fatty Acid Metabolism in Hepatocellular Carcinoma. Hepatic Oncology 2016; 3(4): 241 doi: 10.2217/hep-2016-0012
|
| 85 |
I. G. Nikitin, A. S. Tikhomirova, T. A. Zhinzhilo, E. V. Vinnitskaya, Y. G. Sandler, V. A. Kislyakov, I. G. Fedorov. Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism. The Russian Archives of Internal Medicine 2020; 10(2): 148 doi: 10.20514/2226-6704-2020-10-2-148-154
|
| 86 |
Tingting Shi, Hideki Kobara, Kyoko Oura, Tsutomu Masaki. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. Journal of Hepatocellular Carcinoma 2021; : 45 doi: 10.2147/JHC.S274933
|
| 87 |
Deepak MW Balak, Stefano Piaserico, Ismail Kasujee. Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies. Psoriasis: Targets and Therapy 2021; : 151 doi: 10.2147/PTT.S342911
|
| 88 |
Vahide Betül CANITEZ, İbrahim GÜNEY, Edip ERKUŞ. Metabolik Sendromlu Olmayan Hastalarda Non-Alkolik Yağlı Karaciğer Hastalığı. Batı Karadeniz Tıp Dergisi 2021; 5(2): 143 doi: 10.29058/mjwbs.811398
|
| 89 |
Xing Liu, Wanshui Yang, Jessica L. Petrick, Linda M. Liao, Weibing Wang, Na He, Peter T. Campbell, Zuo-Feng Zhang, Edward Giovannucci, Katherine A. McGlynn, Xuehong Zhang. Higher intake of whole grains and dietary fiber are associated with lower risk of liver cancer and chronic liver disease mortality. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26448-9
|
| 90 |
Paula Iruzubieta, Marta González, Joaquín Cabezas, María Teresa Arias-Loste, Javier Crespo. Liver Research and Clinical Management. 2018; doi: 10.5772/intechopen.72668
|
| 91 |
Fatema Abu-bakr Abdelmoez, Hala Mostafa Imam, Naglaa Kamal Idriss, Lobna Abdel Wahid, Wael Ahmed Abbas, Mohamed Abozaid Ali Abozaid, Hossam Mahmoud Abdelwahab. The Role of Hepatitis C virus and Possible Risk factors in development of Hepatocellular carcinoma: 400 Patients based study. The Egyptian Journal of Internal Medicine 2019; 31(1): 64 doi: 10.4103/ejim.ejim_50_18
|
| 92 |
Dafeng Xu, Yu Wang, Kailun Zhou, Jincai Wu, Zhensheng Zhang, Jiachao Zhang, Zhiwei Yu, Luzheng Liu, Xiangmei Liu, Bidan Li, Jinfang Zheng. <p>Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 8125 doi: 10.2147/OTT.S263047
|
| 93 |
Juliet Emamaullee, Sara Khan, Carly Weaver, Cameron Goldbeck, George Yanni, Rohit Kohli, Yuri Genyk, Shengmei Zhou, Nick Shillingford, Patrick M. Sullivan, Cheryl Takao, Jon Detterich, Paul F. Kantor, John D. Cleveland, Cynthia Herrington, S. Ram Kumar, Vaughn Starnes, Sarah Badran, Neil D. Patel. Non-invasive biomarkers of Fontan-associated liver disease. JHEP Reports 2021; 3(6): 100362 doi: 10.1016/j.jhepr.2021.100362
|
| 94 |
Revathy Carnagarin, Kearney Tan, Leon Adams, Vance B. Matthews, Marcio G. Kiuchi, Leslie Marisol Lugo Gavidia, Gavin W. Lambert, Elisabeth A. Lambert, Lakshini Y. Herat, Markus P. Schlaich. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation. International Journal of Molecular Sciences 2021; 22(8): 4241 doi: 10.3390/ijms22084241
|
| 95 |
Ali Zarrinpar, Claire M. Faltermeier, Vatche G. Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. Liver International 2019; 39(3): 531 doi: 10.1111/liv.14002
|
| 96 |
Ifrath Parveen, Archana Prabhat. Energy Intake and Lifestyle Risk Factors among Non Alcoholic Fatty Liver Disease Patients. The Indian Journal of Nutrition and Dietetics 2020; : 308 doi: 10.21048/ijnd.2020.57.3.25563
|
| 97 |
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice. Drug Development Research 2021; doi: 10.1002/ddr.21905
|
| 98 |
Yanbiao Ai, Zhenzhen Sun, Chuan Peng, Lingli Liu, Xiaoqiu Xiao, Jibin Li. Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice. Nutrients 2017; 9(4): 346 doi: 10.3390/nu9040346
|
| 99 |
Ahmad Hazim, Dyah Purnamasari, Kemal F. Kalista, C. Rinaldi A. Lesmana, Pringgodigdo Nugroho. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 1431 doi: 10.1016/j.dsx.2019.01.058
|
| 100 |
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
|
| 101 |
Mehrnoosh Zakerkish, Abolghasem Assarzadeh, Seyed Saeed Seyedian, Alireza Jahanshahi. Prevalence of Metabolic Syndrome and Related Factors in Patients with Non-alcoholic Fatty Liver. Jundishapur Journal of Chronic Disease Care 2021; 11(1) doi: 10.5812/jjcdc.114541
|
| 102 |
Ryutaro Kuraji, Yvonne Kapila, Yukihiro Numabe. Periodontal Disease and Nonalcoholic Fatty Liver Disease: New Microbiome-Targeted Therapy Based on the Oral–Gut–Liver Axis Concept. Current Oral Health Reports 2022; 9(3): 89 doi: 10.1007/s40496-022-00312-1
|
| 103 |
Qiaoyou Weng, Minjiang Chen, Weibin Yang, Jie Li, Kai Fan, Min Xu, Wei Weng, Xiuling Lv, Shiji Fang, Liyun Zheng, Jingjing Song, Zhongwei Zhao, Xiaoxi Fan, Jiansong Ji. Integrated analyses identify miR‐34c‐3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma. The FASEB Journal 2020; 34(4): 5420 doi: 10.1096/fj.201902895R
|
| 104 |
|
| 105 |
I. Mikolasevic, S. Milic, L. Orlic, G. Poropat, I. Jakopcic, N. Franjic, A. Klanac, N. Kristo, D. Stimac. Metabolic syndrome and acute pancreatitis. European Journal of Internal Medicine 2016; 32: 79 doi: 10.1016/j.ejim.2016.04.004
|
| 106 |
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>®</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
|
| 107 |
Laura Inés Elvira-Torales, Gala Martín-Pozuelo, Rocío González-Barrio, Inmaculada Navarro-González, Francisco-José Pallarés, Marina Santaella, Javier García-Alonso, Ángel Sevilla, María Jesús Periago-Castón. Ameliorative Effect of Spinach on Non-Alcoholic Fatty Liver Disease Induced in Rats by a High-Fat Diet. International Journal of Molecular Sciences 2019; 20(7): 1662 doi: 10.3390/ijms20071662
|
| 108 |
Min Wang, Minxian Wang, Ru Zhang, Chao Shen, Liuxin Zhang, Yajie Ding, Zongzhe Tang, Hongliang Wang, Wei Zhang, Yue Chen, Jie Wang. Influences of Vitamin D Levels and Vitamin D-Binding Protein Polymorphisms on Nonalcoholic Fatty Liver Disease Risk in a Chinese Population. Annals of Nutrition and Metabolism 2022; 78(2): 61 doi: 10.1159/000522193
|
| 109 |
Dora Lucía Vallejo-Ardila, Marco A. De Bastiani, Diego A. Salazar. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 193 doi: 10.1007/16833_2022_40
|
| 110 |
Ahmet UYANIKOĞLU. Siroz etiyolojisinde steatohepatitin yeri nedir?. Akademik Gastroenteroloji Dergisi 2019; 19(1): 17 doi: 10.17941/agd.723285
|
| 111 |
Hsien Min Low, Jin Young Choi, Cher Heng Tan. Pathological variants of hepatocellular carcinoma on MRI: emphasis on histopathologic correlation. Abdominal Radiology 2019; 44(2): 493 doi: 10.1007/s00261-018-1749-z
|
| 112 |
Ryutaro Kuraji, Satoshi Sekino, Yvonne Kapila, Yukihiro Numabe. Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis. Periodontology 2000 2021; 87(1): 204 doi: 10.1111/prd.12387
|
| 113 |
Thomas J. Vogl, Tatjana Gruber-Rouh. HCC: Transarterial Therapies—What the Interventional Radiologist Can Offer. Digestive Diseases and Sciences 2019; 64(4): 959 doi: 10.1007/s10620-019-05542-5
|
| 114 |
Chenyi Wang, Qianglong Niu, Haihong Lv, Qian Li, Yuping Ma, Jiaojiao Tan, Chunhua Liu. <p>Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 4369 doi: 10.2147/DMSO.S280231
|
| 115 |
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn. A micro-RNA expression signature for human NAFLD progression. Journal of Gastroenterology 2016; 51(10): 1022 doi: 10.1007/s00535-016-1178-0
|
| 116 |
John D. Clarke, Anika Dzierlenga, Tarana Arman, Erica Toth, Hui Li, Katherine D. Lynch, Dan-Dan Tian, Michael Goedken, Mary F. Paine, Nathan Cherrington. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity. Toxicon 2019; 162: 1 doi: 10.1016/j.toxicon.2019.03.002
|
| 117 |
Sarawoot Bunbupha, Poungrat Pakdeechote, Putcharawipa Maneesai, Patoomporn Prasarttong. Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats. The Journal of Nutritional Biochemistry 2021; 87: 108526 doi: 10.1016/j.jnutbio.2020.108526
|